Japanese Renewable Energy Stock News

TSE:4568
TSE:4568Pharmaceuticals

ENHERTU’s Early Breast Cancer Approval Might Change The Case For Investing In Daiichi Sankyo Company (TSE:4568)

Daiichi Sankyo and AstraZeneca recently received US FDA approval for ENHERTU in both neoadjuvant and adjuvant treatment of HER2-positive early breast cancer, unlocking US$155 million in milestone payments to Daiichi Sankyo and adding to an already broad label that spans multiple tumor types and disease stages. This move brings ENHERTU into earlier, potentially curative treatment settings while reinforcing Daiichi Sankyo’s DXd-based antibody-drug conjugate platform as a central pillar of its...